Concepedia

Publication | Closed Access

Low‐dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation

DOI

42

Citations

22

References

2013

Year

Koji Kawamura, Hidenori Wada, Ryo Yamasaki, Yu Ishihara, Kana Sakamoto, Masahiro Ashizawa, Miki Sato, Tomohito Machishima, Kiriko Terasako, Shun‐ichi Kimura,
Transplant Infectious Disease

Abstract

ACV at 200 mg/day appeared to be effective for preventing HSV disease in the early phase after HSCT.

References

YearCitations

Page 1